From HandWiki - Reading time: 6 min
| retinoid X receptor alpha | |
|---|---|
| Identifiers | |
| Symbol | RXRA |
| NCBI gene | 6256 |
| HGNC | 10477 |
| OMIM | 180245 |
| RefSeq | NM_002957 |
| UniProt | P19793 |
| Other data | |
| Locus | Chr. 9 q34 |
| retinoid X receptor beta | |
|---|---|
| Identifiers | |
| Symbol | RXRB |
| NCBI gene | 6257 |
| HGNC | 10478 |
| OMIM | 180246 |
| RefSeq | NM_021976 |
| UniProt | P28702 |
| Other data | |
| Locus | Chr. 6 p21.3 |
| retinoid X receptor gamma | |
|---|---|
| Identifiers | |
| Symbol | RXRG |
| NCBI gene | 6258 |
| HGNC | 10479 |
| OMIM | 180247 |
| RefSeq | NM_006917 |
| UniProt | P48443 |
| Other data | |
| Locus | Chr. 1 q22-q23 |
The retinoid X receptor (RXR)[1] is an important family of transcription factors that can combine with various nuclear receptors to form a protein dimer, which is often needed for those receptors to perform their functions. It is also a nuclear receptor which is activated by 9-cis retinoic acid, but whether its role as a direct endogenous receptor is important biologically is controversial.[2][3] It can also bind to 9-cis-13,14-dihydroretinoic acid, which may be an endogenous mammalian RXR-selective agonist.[4] Bexarotene is the only FDA-approved medication that selectively activates the RXRs while exhibiting negligible activity toward the retinoic acid receptors.[5]
There are three retinoic X receptors (RXR): RXR-alpha, RXR-beta, and RXR-gamma, encoded by the RXRA, RXRB, RXRG genes, respectively.
RXR heterodimerizes with multiple nuclear receptors including CAR, FXR, LXR, PPAR,[6] PXR, RAR, TR, ER and VDR. RXRs are permissive co-receptors as only one of six alleles is needed for normal development and health.[7] Given this, it is difficult to extrapolate whether the RXR pathway has its own endogenous activity driven by 9-cis retinoic acid species or whether it merely participates in other pathways, predominantly the retinoic nuclear receptor pathway. Genomic knockout of the RXRs results in obesity resistance[8] while bexarotene treatment causes severe hypothyroidism,[9] suggesting that the RXR pathway functions at least to regulate the thyroid hormone receptor pathway.
The retinoid X receptors are selectively targeted by certain pharmaceutical retinoids, in particular as part of cancer treatments or to treat severe hand eczema. These including bexarotene and alitretinoin (synthetic 9-cis-retinoic acid), though with the caveat that alitretinoin also has some affinity for the Retinoic Acid Receptors (RARs).[10]